Cofactor Genomics has appointed Steven Daniel as VP of business development. Daniel previously served as senior director of applied sciences and business development at ArcherDx. Prior to ArcherDx, he was VP of sales at Genos/Nantomics, senior director of pharma business development at Adaptive Biotechnologies, and held commercial roles at Life Technologies, AltheaDX, Metabolon, and Affymetrix.
Novigenix has appointed Francois Martelet as a non-executive director. Martelet recently retired as CEO at NetScientific. He was also chairman of several companies, including Vortex BioSciences, Wanda, Glycotest, and ProAxsis. Prior to that, Martelet was CEO at Topotarget and held senior commercial roles at Novartis Pharma and Merck.
Microbiome Insights has appointed Don Enns as an independent member of its board of directors. Enns currently serves as VP and head of global drug delivery at Evonik Industries, joining the firm in 2016 with its acquisition of Transferra Nanoscience, where he served as president and CEO. Prior to Transferra, Enns was president and CEO at Cantest before the firm was acquired by Maxxam Analytics in 2009.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.